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SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of niacin (nicotinic acid and 
nicotinamide) as a feed additive for all animal species based on a dossier 
submitted by Vertellus Specialties Belgium BV
1, 2 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
3, 4 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The term ‘niacin’ is used as a generic description of nicotinic acid and nicotinamide with pyridine as the basic 
structure. Nicotinic acid and nicotinamide function mainly as precursors of the co-enzymes NAD and NADP. 
Thus,  nicotinamide  has  physiologically  critical  roles  in  mitochondrial  respiration  and  in  the  metabolism  of 
carbohydrates, lipids, and amino acids. Niacin is safe for the target animals with a margin of safety that is at least 
ten times the requirements and use levels. The FEEDAP Panel assumes that exposure figures for a population 
already  include  the  contribution  of  edible  tissues  and  products  of  animals  fed  niacin-supplemented  diets. 
Information on niacin metabolism and the limited data available on retention in edible tissues and products 
indicate that supplemental levels in feeds even far higher than the requirements (1–35 mg/kg feed) are highly 
unlikely to lead the tolerable upper intake level being exceeded. The FEEDAP Panel considers that the use of 
niacin in animal nutrition is not of safety concern for consumers. Nicotinic acid and nicotinamide are not irritant 
to skin, but can cause irritancy to eyes and mucous membranes. They are unlikely to cause skin sensitisation. 
Workers might be exposed to a respirable dust when handling nicotinic acid and nicotinamide, which should be 
regarded as being potentially harmful to their health. The use of nicotinic acid and nicotinamide in animal 
nutrition does not pose a risk to the environment. Nicotinic acid and nicotinamide are regarded as effective 
sources of niacin in animal nutrition. 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of nicotinic acid and nicotinamide as feed additives for all animal species. 
The term ‘niacin’ is used as a generic description of nicotinic acid and nicotinamide with pyridine as 
the basic structure. Niacin is widely distributed and occurs in large quantities in yeasts, brans and food 
of animal origin. Nicotinic acid and nicotinamide function mainly as precursors of the co-enzymes 
NAD and NADP. Thus, nicotinamide has physiologically critical roles in mitochondrial respiration 
and in the metabolism of carbohydrates, lipids, and amino acids. 
Niacin is safe for the target animals with a margin of safety that is at least ten times the requirements 
and use levels. 
The FEEDAP Panel assumes that exposure figures for a population already include the contribution of 
edible  tissues  and  products  of  animals  fed  niacin-supplemented  diets.  Information  on  niacin 
metabolism and the limited data available on retention in edible tissues and products indicate that 
supplemental  levels  in feeds  even  far  higher  than the  requirements  (1–35 mg/kg  feed)  are  highly 
unlikely to lead the tolerable upper intake level being exceeded. The FEEDAP Panel considers that the 
use of niacin in animal nutrition is not of safety concern for consumers. 
The FEEDAP Panel considers that nicotinic acid and nicotinamide are not irritant to skin, but it can 
cause irritancy to eyes and mucous membranes. They are unlikely to cause skin sensitisation. Workers 
might be exposed to a respirable dust when handling nicotinic acid and nicotinamide, which should be 
regarded as being potentially harmful to their health. 
The use of nicotinic acid and nicotinamide in animal nutrition does not pose a risk to the environment. 
Nicotinic acid and nicotinamide are regarded as effective sources of niacin in animal nutrition. Nicotinic acid and nicotinamide for all animal species 
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BACKGROUND 
Regulation  (EC)  No  1831/2003
5  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7; in addition Article 10(2) of that Regulation also specifies that 
for existing products within the meaning of Article 10(1), an application shall be submitted in 
accordance with Article 7, at the latest one year before the expiry date of the authorisation given 
pursuant to Directive 70/524/EEC for add itives with a limited authorisation period, and within a 
maximum of seven years after the entry into force of this Regulation for additives authorised without 
time limit or pursuant to Directive 82/471/EEC. 
The European Commission received a request from t he company Vertellus Specialties Belgium BV
6 
for the re-evaluation of the products nicotinic acid and nicotinamide, when used as feed additives for 
all  animal  species   (category:  nutritional  additive;  functional  group:  vitamins,  provitamins  and 
chemically well-defined substances having similar effect) under the conditions mentioned in Table 1. 
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application to the European Food Safety Authority (EFSA) as an application unde r Article 10(2) (re-
evaluation of an authorised feed additive). EFSA received directly from the applicant the technical 
dossier in support of this application.
7 According to Article 8 of that Regulation, EFSA, after verifying 
the particulars and documents  submitted by the applicant, shall undertake an assessment in order to 
determine whether the feed additive complies with the conditions laid down in Article 5. The 
particulars and documents in support of the application were considered valid by EFSA as of  20 July 
2011.
8 
Nicotinic  acid  in  the  form  of  nicotinic  acid  (niacin)   and  nicotinic  acid  amide  (nicotinamide -
niacinamide, NA) has been authorised without time limit under Council Directive 70/524/EEC
9 for its 
use for all animal species as a nutritional additive. 
The Scientific Committee on Food (SCF) expressed an opinion on the tolerable upper intake level of 
nicotinic acid and nicotinamide (niacin)  (SCF, 2002). The Panel on  Food Additives and Nutrient 
Sources added to food (ANS) issued an opinion on inositol hexanicotinate (inositol hexaniacinate) as a 
source of niacin (vitamin B3) added for nutritional purposes in food supplements (EFSA, 2009a) and 
an opinion on the inability to assess the safety of niacin-enriched yeast added for nutritional purposes 
as a source of niacin in food supplements and the bioavailability of niacin from this source, based on 
the supporting dossier (EFSA, 2009b). The NDA Panel expressed two opinions on the substantiation 
of several health claims related to niacin pursuant to Article 13(1) of Regulation (EC) No 1924/2006 
(EFSA, 2009c, 2010). The FEEDAP Panel issued an opinion on the safety and efficacy of niacin 
(nicotinamide) as a feed additive for all animal species (EFSA, 2012). 
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of nicotinic acid 
and nicotinamide, when used under the conditions described in Table 1. 
                                                       
5   Regulation (EC) 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in 
animal nutrition. OJ L 268, 18.10.2003, p. 29. 
6   Vertellus Specilaties Belgium BV, Haven 611, Tijsmanstunnel West, 2040 Antwerp, Belgium. 
7   EFSA Dossier reference: FAD-2010-0265. 
8  A new mandate was received in EFSA in March 2011. 
9  Commission List of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01). OJ C 50, 25.2.2004, p. 1. Nicotinic acid and nicotinamide for all animal species 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   Vitamin B3 (Niacin) 
Registration number/EC No/No 
CAS No.: 59-67-6 & 98-92-0 
EC-No.: 200-441-0 & 202-713-4 
Category(ies) of additive  Category 3: Nutritional Additives 
Functional group(s) of additive  Functional  Group  A:  Vitamins,  pro-vitamins  and  chemically  well 
defined substances having a similar effect 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
 
Method of analysis 
 
>99.5% Pure Active Substance as 
white crystalline product 
C6H5NO2 
C6H6N2O  > 99.5 %  European 
Pharmacopoeia 
 
Trade name    
Name  of  the  holder  of 
authorisation  
 
 
Conditions of use 
Species  or 
category  of 
animal 
Maximum Age 
Minimum content  Maximum content 
Withdrawal period 
  mg or Units of activity or CFU/kg of complete 
feedingstuffs  (select what applicable) 
All  No restriction  no minimum proposed  no maximum proposed       - 
 
Other provisions and additional requirements for the labelling 
Specific  conditions  or  restrictions 
for use  
None  
Specific  conditions  or  restrictions 
for handling  
Suitable PPE for handling 
Post-market monitoring   - 
Specific  conditions  for  use  in 
complementary feedingstuffs  
- 
 
Maximum Residue Limit (MRL)  
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
-  -  -  - 
 Nicotinic acid and nicotinamide for all animal species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  single  company  involved  in  the 
production/distribution of nicotinic acid and nicotinamide. It should be recognised that these data 
cover only a fraction of existing additives containing nicotinic acid and nicotinamide. The application 
is for the active substance and the composition of the additive formulations is not the subject of the 
application. The Panel has sought to use the data provided together with data from other sources to 
deliver an opinion. 
1.  Introduction 
The term ‘niacin’ is used as a generic description of nicotinic acid and nicotinamide (niacinamide) 
with pyridine as the basic structure. Niacin is widely distributed and occurs in large quantities in 
yeasts, brans and food of animal origin. Nicotinic acid and nicotinamide function mainly as precursors 
of  the  co-enzymes  NAD  and  NADP.  Thus,  nicotinamide  has  physiologically  critical  roles  in 
mitochondrial respiration and in the metabolism of carbohydrates, lipids and amino acids. 
Niacin in the form of nicotinic acid (niacin) and nicotinic acid amide (nicotinamide–niacinamide, NA) 
is  included  in  the  European  Union  Register  of  Feed  Additives  pursuant  to  Regulation  (EC)  No 
1831/2003. It is authorised without a time limit in application of Article 9t (b) of Council Directive 
70/524/EEC
10 concerning additives in feedingstuffs (2004/C 50/01) for use in all animal species as a 
nutritional additive. No maximum levels of nicotinic acid in feeds are established in the EU. 
The applicant asks for the re-evaluation of the use of  nicotinic acid and nicotinamide as additives to 
feed for all animal species and categories without restrictions for age, (withdrawal) time and content in 
feedingstuffs. 
Niacin  as  nicotinic  acid and  nicotinamide is authorised for use in food ( Regulation  (EC)  No 
1925/2006,
11  amended  by  Regulation  (EC)  No  1170/2009 )
12  and  food  s upplements  (Directive 
2002/46/EC,  Annex  II ),
13  for  addition  for  specific  nutritional  purposes  to  foods  for  particular 
nutritional uses (Regulation (EC) No 953/2009),
14 and for addition to processed cereal -based foods 
and baby foods for infants and young chil dren (Directive 2006/125/EC, Annex IV)
15 and to infant 
formulae and follow-on formulae when reconstituted as instructed by the manufacturer (Directive 
2006/141/EC, Annex III).
16 Niacin (as vitamin B3) is also listed as pharmacologically active substance 
in veterinary medicinal products and it is not subject to maximum residue levels when used in food-
producing animals (Commission Regulation (EC) No 37/2010).
17 Nicotinic acid is authorised for the 
treatment of dyslipidaemias (EMEA/H/C/000889).  
Nicotinic acid and nicotinamide are described in the European Pharmacopeia (PhEur) in Monographs 
(MG) 0459 and 0047, respectively. 
                                                       
10   Commission List of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01). OJ C 50, 25.2.2004, p. 1. 
11   Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404 30.12.2006, p. 26. 
12   Commission Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European 
Parliament and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards 
the lists of vitamin and minerals and their forms that can be added to foods, including food supplements. OJ L 314 
1.12.2009, p. 36. 
13   Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183 12.7.2002, p. 51. 
14   Commission Regulation (EC) 953/2009 of 13 October 2009 on substances that may added for specific nutritional purposes 
in foods for particular nutritional uses. OJ L 269, 14.10.2009, p. 9. 
15   Commission Directive 2006/125 EC of 5 December 2006 on processed cereal-based foods and baby-foods for infants and 
young children. OJ L 339 6.12.2006, p. 16. 
16   Commission Directive 2006/141 EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC. OJ L 401 30.12.2006, p. 1. 
17   Commission Regulation (EU) 37/2010 of 22 December 2009 on pharmacologically active substances and their 
classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1. Nicotinic acid and nicotinamide for all animal species 
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2.  Characterisation
18 
2.1.  Characterisation of the active substance 
2.1.1.  Nicotinic acid 
Nicotinic acid (IUPAC name: 3-pyridine carboxylic acid, synonyms: niacin, vitamin B3, vitamin PP) is 
identified by the CAS (Chemical Abstracts Service)  number 59-67-6 and the EINECS (European 
Inventory of Existing Chemical Substances) number 200-441-0. The structural formula of nicotinic 
acid is shown in Figure 1. 
       
Figure 1:   Structural formula of nicotinic acid 
The molecular formula of nicotinic acid is C6H5NO2 and its molecular weight is 123.11. It has a pKa of 
4.85, a log POW of -0.59 (at pH = 4 and 25 °C), a melting point of 237 °C, a boiling point of > 238 °C, 
shows a density of 1.473 g/cm
3, and a vapour pressure of < 0.01 kPa (at 20 °C). It is soluble in water 
(17 g/L at 20 °C) and glycol, freely soluble in boiling water and alcohol, in alkali hydroxides and 
carbonates, and insoluble in ether. 
Nicotinic acid is a white odourless powder or granules. Nicotinic acid is described in the European 
Pharmacopoeia (PhEur 7.0, 0459) with a purity of 99.5–100.5 % pyridine-3-carboxylic acid in dried 
substance,  less  than  0.5  %  related  substances,  <  200  mg  chlorides/kg,  <10  mg  heavy  metals/kg 
(calculated as Pb), ≤ 1 % loss on drying and ≤ 0.1 % sulphated ash. The additive contains at least 99.5 
% of the active substance by specification. Analysis of five batches of the product showed an average 
(± SD) content of niacin of 100.1 ± 0.3 %,
19 in compliance with PhEur 0459. 
The applicant provided analytical results of three batches of nicotinic acid. Related impurities were < 
0.01 %, total impurities < 0.05 %, chloride was < 0.02 %, loss on drying ranged between 0.07 and 0.09 
%,  sulphated ash between 0.038   %  and 0.055 %.
20  All parameters comply with PhEur.  Benzene 
determined in six batches was below 0.05 mg/kg and   conformed  with the corresponding VICH 
(International  Cooperation  on  Harmonisation  of  Technical  Requirements  for  Registration  o f 
Veterinary Medicinal Products) threshold (class 1 solvent, VICH ≤ 2 mg/kg). The active substance 
(nine batches) contained < 1 mg As/kg, < 0.1 mg Cd/kg, < 0.1 mg Hg/kg, < 4 mg Pb/kg, and < 0.25 ng 
WHO-PCDD/F-TEQ/kg (four batches).
21 
Five batches of nicotinic acid were analysed for  particle size distribution  by sieving. The particle 
fraction below 100 µm was about 4 % (w/w).
22 The particle fraction below 50 µm was determined by 
laser diffraction in three additional batches and ranged between 1.15  % and 1.7 % (v/v). The results 
obtained by the Stauber-Heubach test for one batch of nicotinic acid showed a dusting potential, with 
values of 0.55–0.64 g/m³ (duplicate analysis).
23 
                                                       
18   This section has been edited following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003. 
19   Technical dossier/Section II/Annex II.4 
20   Technical dossier/Supplementary information February 2012. 
21   Technical dossier/Section II/Annex II.5. 
22   Technical dossier/Section II/Annex II.10. 
23   Technical dossier/Supplementary information February 2012. Nicotinic acid and nicotinamide for all animal species 
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Nicotinic acid is produced by chemical synthesis. The applicant provided a flow-chart of the synthetic 
process. An HACCP system is in place to control the raw material quality standards and for the 
prevention of contamination of the final products. 
2.1.2.  Nicotinamide 
Nicotinamide  (IUPAC  name:  3-pyridinecarboxamide,  synonyms:  nicotinamide,  vitamin  B3)  is 
identified by the CAS number 98-92-0 and the EINECS number 202-713-4. The structural formula of 
nicotinamide is shown in Figure 2. 
       
Figure 2:  Structural formula of nicotinamide 
The molecular formula of nicotinamide is C6H6N2O and its molecular weight is 122.11. It has a pKa of 
3.3, a log POW of -0.38 , a melting point of 128–131 °C, a boiling point of 224 °C, and shows a density 
of approximately 1.4 g/cm
3, and a vapour pressure of 3.14 kPa (at 25 °C). It is soluble in water (1000 
g/L at 20 °C), ethanol (670 g/L) and glycerol (100 g/L).  
Nicotinamide  is  a  white  or  almost  white  odourless  crystalline  powder  or  colourless  crystals. 
Nicotinamide is described in the European Pharmacopoeia (PhEur 7.0, 0047) with a purity of 99.0–
101.0 %  pyridine-3-carboxamide  in  dried  substance,  less than  0.25  %  related  substances,  loss on 
drying < 0.5 %, sulphated ash < 0.1 % and heavy metals (calculated as Pb) < 30 mg/kg. The additive 
contains at least 99.5 % nicotinamide by specification. Analysis of five batches of the product showed 
an average (± SD) nicotinamide content of 100.0 ± 0.1 %,
24 in compliance with PhEur 0047. 
Related impurities  (three batches)  were not detected, chloride was below  0.02 %, loss on drying 
ranged between 0.022   %  and 0.027 %,   and sulphated ash  between 0.72  %  and 0.73 %   (three 
batches).
25 All parameters except sulphated ash complied with PhEur 0047. The applicant stated that 
no single impurity is higher than 0.005 %. Benzene determined in six batches was below 0.05 mg/kg 
and conformed with the corresponding VICH threshold (class 1 solvent, VICH ≤ 2 mg/kg). The active 
substance (eight batches) contained < 1 mg As/kg, < 0.1 mg Cd/kg, < 0.1 mg Hg/kg, < 1 mg Pb/kg, < 
20 mg F/kg (six batches) and < 0.25 ng WHO-PCDD/F-TEQ/kg (six batches).
26 
Five batches of nicot inamide were analysed for particle size distribution by sieving. The particle 
fraction below 32 and 100 µm ranged from 0.4   %  to 0.7 %, and from 2.0   %  to 3.1 %  (w/w), 
respectively.
27  The particle fraction below 50 µm   was determined by laser diffraction in th ree 
additional batches and ranged between 1.1 % and 1.15 % (v/v). The results obtained by the Stauber-
Heubach test  for one batch of nicotinamide showed a  dusting potential  of approximately 1.0 g/m³ 
(duplicate analysis).
28 
Nicotinamide is produced by chemical synthesis. The applicant provided a flow-chart of the synthetic 
process. An HACCP system is in place to control the raw material quality standards and for the 
prevention of contamination of the final products. 
                                                       
24   Technical dossier/Section II/Annex II.8. 
25   Technical dossier/Supplementary information February 2012. 
26   Technical dossier/Section II/Annex II.9. 
27   Technical dossier/Section II/Annex II.11. 
28   Technical dossier/Supplementary information February 2012. Nicotinic acid and nicotinamide for all animal species 
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2.2.  Stability and homogeneity 
Nicotinic acid and nicotinamide are very stable in air and to heat, light, acids and alkalis.  
2.2.1.  Shelf-life of the additives 
The applicant provided information on the recovery of nicotinic acid (five batches) and nicotinamide 
(eight batches) when stored in the unopened container under practical conditions with an average 
temperature of 16 °C (0.3–29.8 °C) up to 60 months for nicotinic acid and up to 36 months for 
nicotinamide.  The  recovery  values  showed  no  reduction  of  the  content  of  nicotinic  acid  and 
nicotinamide over time.
29 
2.2.2.  Stability of the additive when added to premixtures and feed  
Information on the stability of nicotinic acid and nicotinamide in premixtures, in compound feed and 
during feed processing was not provided, even upon request. 
According  to  published  literature  (substance  identity  not  given),  a  loss  of  niacin  in  premixtures 
containing trace minerals up to 18 % could be expected after 27 weeks storage at 43  C (Zhuge and 
Klopfenstein, 1985). Additional stability data for nicotinic acid and nicotinamide showed losses up to 
30 % and 36 % in premixtures containing choline chloride and trace minerals, respectively, after six-
month storage (BASF, 2001).
30 
In commercial fish feed (Marchetti et al., 1999)  the initial concentration of crystalline nicotinamide 
(396 mg/kg) was reduced by 4 % after pelleting and by 8 % after extrusion. Nicotinamide in pelleted 
and extruded feed was stable for another 90 days. 
2.2.3.  Homogeneity 
Based on a statistical method (Jansen, 1992), the coefficient of variation (CV) for homogeneity of 
nicotinamide in feed for poultry, piglets, calves and cats was calculated to be around 9.4, 6.2, 0.9 and 
4.5 %, respectively.
31 For nicotinic acid, the CV  was calculated to be 15.8  % and 12.9 % at the 
inclusion levels of 40 and 60 mg/kg and an average daily feed intake of 30 g per chicken.
32 However, 
this method has been developed to test the working accuracy of mixing equipment. 
2.3.  Physico-chemical incompatibilities in feed 
No physico-chemical incompatibilities or interactions have been reported between nicotinic acid and 
nicotinamide and feed materials, carriers, other approved additives or medicinal products when the 
additive was added to premixtures and feed. 
2.4.  Conditions of use 
Niacin in the form of nicotinic acid and nicotinamide is intended for use via feed in all animal species 
and categories without a maximum content and a withdrawal period. 
2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of niacin (nicotinic 
acid) and niacinamide (nicotinamide) in animal feed. The Executive Summary of the EURL report can 
be found in the Appendix.  
                                                       
29   Technical dossier/Section II and Annexes II.4 and II.8. 
30   Vitamin Stability in Premixes and Feeds: A Practical Approach, BASF Fine Chemicals. Know-how and quality for the eed 
industry.  KC 9138, 6
th Revision, 2001. 
31   Technical dossier/Section II/Annex II.32. 
32   Technical dossier/Supplementary information February 2012. Nicotinic acid and nicotinamide for all animal species 
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3.  Safety 
According to Regulation (EC) No 429/2008, tolerance, metabolism and residue, and toxicological 
(concerning  consumer  safety)  studies  are  not  required  for  vitamins,  pro-vitamins  and  chemically 
defined  substances  having  similar  effects  which  are  already  authorised  as  feed  additives  under 
Directive 70/524/EEC and which do not have the potential to accumulate, which FEEDAP considers is 
the case for niacin. 
3.1.  Safety for the target species  
The requirements for available niacin are in the range 12.5–20 mg/kg for piglets (3–20 kg bw), 7–
1 mg/kg for grower/finisher pigs and 10 mg/kg diet for gestating/lactating sows (NRC, 1998). Laying 
hens  and  chickens  for  fattening  require  about  8.3–12.5  and  25–35 mg/kg  niacin  in  their  diet, 
respectively (NRC, 1994). For growing and adult dogs, 13.6 mg niacin/kg dry matter (DM) appears to 
be adequate, and for kittens and adult cats about 32 mg/kg DM (NRC, 2006). Deficiencies of niacin 
are unlikely to occur under the present feeding practices. 
Vitamin supplementation of commercial compound feed is mostly oriented  towards recommended 
allowances in the range of 8–20 mg/kg for pigs, 25–100 mg/kg for poultry, 60–160 mg/kg for fish and 
20–60 mg/kg feed for pets (AWT, 2002). A survey of vitamin supplementation of commercial feeds 
for pigs and poultry in Europe (Belgium, Denmark, Germany, Italy, Netherlands, Portugal, Spain, 
United Kingdom) identified a range of 0–100 mg niacin/kg as commercial use levels (Gropp, 1994). A 
range for piglets and pigs of 10–40 mg niacin/kg feed was reported by Whittemore et al. (2002). 
The  data  on  the  toxicity  of  niacin  (nicotinic  acid  and  nicotinamide)  are  partially  inconsistent.  In 
finishing pigs the addition of 550 mg niacin per kilogram diet appeared to reduce feed intake and 
weight gain when compared with lower additions; concentrations up to 110 mg niacin/kg feed showed 
no  adverse  effect  on  performance  and  carcass  characteristics  (Real  et  al.,  2002).  Experiments  in 
chickens fed 1 000–20 000 mg/kg in standard chicken diets indicate that high levels of supplemental 
niacin (10 000 mg/kg and above) resulted in decreased tibia weights and bone strength in chicks, 
decreases in tibia dimensions with no change in mineral content of the tibiae, and susceptibility to 
fracture (Johnson et al., 1992, 1995). It seems that nicotinic acid is better tolerated than nicotinamide, 
since 5 000 and 10 000 mg/kg nicotinamide caused a slight and marked growth depression, whereas 
20 000 mg/kg of dietary nicotinic acid did not affect growth in chickens (Baker et al., 1976). 
According to McDowell (2000) and NRC (1987) non-ruminant species evidently tolerate oral niacin 
exposures of at least 10–20 times their normal requirements. It is supposed that a level of 350 mg 
nicotinamide/kg bw and around 1 400 mg nicotinic acid/kg  bw  may be safe for chronic exposure 
(NRC, 1987).  
3.1.1.  Conclusions on the safety of niacin in target species 
Niacin is safe for the target animals with a margin of safety that is at least ten times the requirements 
and use levels. 
3.2.  Safety for the consumer 
3.2.1.  Absorption, distribution, metabolism and excretion of niacin 
In nature nicotinamide is primarily found in animal tissues (as NAD or NADP), whereas nicotinic acid 
is present in plants. Nicotinic acid and nicotinamide mainly occur in bound forms. In grains, nicotinic 
acid is bound to macromolecules which are contained in cellulose or hemicellulose (Mason et al., 
1973). Accordingly, the niacin in yellow corn, oats, wheat and grain sorghum is evidently largely 
unavailable to young pigs, whereas the availability of niacin in soybean meal is high, at least for 
chicks (Luce et al., 1966; Harmon et al., 1969, 1970; Yen et al., 1977; NRC, 1998). Nicotinamide can 
also be synthesised in target animals (except the cat) from tryptophan; however, the efficacy of this 
route is low. Nicotinic acid and nicotinamide for all animal species 
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Free nicotinic acid and nicotinamide are readily absorbed from the stomach and the small intestine by 
passive  diffusion  or  by  a  Na
+-dependent  carrier-mediated  facilitated  diffusion.  However,  at 
pharmacological doses the passive diffusion predominates. Once absorbed into the intestinal mucosa, 
nicotinic acid is converted to nicotinamide via nicotinic acid mononucleotide to form the nicotinic acid 
analogue  of  NAD  and  subsequently  NAD  and  finally  enzymatic  cleavage  takes  place  to  form 
nicotinamide. The intestinal mucosa and liver are rich in niacin conversion enzymes, such as NAD 
glycohydrolase, which releases nicotinamide from NAD. Nicotinamide, the predominant circulating 
form  of  the  vitamin,  is  transported  to tissues  for  the  synthesis  of  NAD  or  NADP.  The  principal 
excretory product is the methylated, water-soluble metabolite N
1-methyl-nicotinamide or some of its 
oxidation products (e.g. Huff and Perlzweig, 1943, 1945; Knox and Grossman, 1946; Perlzweig et al., 
1950; Reddi and Kodicek, 1953; Chang and Johnson, 1959, 1961; Shibata and Matsuo, 1989a, b, 
1990; Shibata et al., 1990). A detailed description of the absorption and metabolism of nicotinic acid 
and nicotinamide can be found in McDowell (2000) and SCF assessment (EC, 2002). 
Based on a range of measurements, niacin tissue levels are taken to be 50–74 mg/kg meat, about 140–
180 mg/kg liver, 0.8 mg/kg fresh egg, 0.46–0.87 mg/kg milk and 47–65 mg/kg fish flesh (Leeson and 
Caston, 2003; Niehoff et al., 2009; CIV-INRA, 2010; USDA National Nutrient Database). 
Although niacin is generally considered as being rapidly eliminated, without significant potential for 
tissue retention above physiological levels, a few studies show increased deposition after feeding high 
levels to laying hens (about +65 % in eggs) and after duodenal administration (about +75 % in milk) 
(Wagner et al., 1997; Leeson and Caston, 2003). However, another study found a correlation between 
high oral concentrations and lower milk niacin concentration (Nilson et al., 1967). 
3.2.2.  Toxicological studies 
The SCF (EC, 2002) carried out a comprehensive overview of the toxicological profile of nicotinic 
acid  and  nicotinamide  including  data  and  effects  in  humans  and  animals.  Genotoxicity  tests  on 
nicotinic acid and nicotinamide gave negative results. Most of these studies in humans considered the 
known  vasodilatory  effects,  gastrointestinal  effects,  hepatotoxicity  and  glucose  intolerance.  There 
were no reliable multigeneration studies of reproductive toxicity, but a rat developmental study on 
nicotinic acid showed no teratogenicity at 1 000 mg/kg bw per day and a NOAEL (no observable 
adverse effect level) for maternal toxicity and fetotoxicity of 200 mg/kg bw per day (OECD SIDS, 
2002). A 4-week rat feeding study with nicotinamide showed increased liver weight, centrilobular 
hepatocellular  hypertrophy  with  (in  females)  extramedullary  haematopoiesis  in  the  spleen  at 
1 000 mg/kg bw per day with a NOAEL of 215 mg/kg bw per day (OECD SIDS, 2002). 
3.2.3.  Tolerable upper intake level (UL) 
Because  of  the  difference  in  adverse effect  profiles,  different  upper levels  have  been  defined for 
nicotinic acid and nicotinamide. 
The SCF (EC, 2002) defined a UL for nicotinic acid of 10 mg/day in adults, based on the available 
data indicating facial flushing at 30 mg/day, using an uncertainty factor of 3 to allow for the fact that a 
slight effect was reported, and that the study was performed in a small number of subjects, but taking 
into account the steep dose–response relationship. The EVM (2003) identified a guidance level (GL) 
of 17 mg/day based on a lowest observed effect level (LOEL) for facial flushing of 50 mg/day. 
Nicotinamide does not produce the above-mentioned flushing response The UL for nicotinamide is 
established at 12.5 mg/kg bw per day for adults. This was derived from evidence of no adverse effect 
at doses up to 25 mg/kg bw per day in prolonged studies in diabetic subjects. An uncertainty factor of 
2 was applied (EC, 2002). The EVM (2003) identified a GL of 560 mg/day. 
Owing to the absence of data, the UL for nicotinic acid should not be applied to pregnant and lactating 
women (EC, 2002); the GL for nicotinamide should not be applied to pregnant women (EVM, 2003). Nicotinic acid and nicotinamide for all animal species 
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3.2.4.  Consumer exposure 
The most important sources of nicotinamide (in form of NAD and NADP) are foods of animal origin 
(liver, meat and fish flesh, eggs and milk listed in a decreasing order; see section 3.2.1). 
According to the SCF opinion (EC, 2002), the background intake of niacin equivalents was in the 
range of 11.6 (Germany) to 40.9 (UK) mg/person per day; most of the 97.5th percentile values were in 
the range of 20.5 (Germany) to 67.4 (UK) mg/person per day, showing no risk of exceeding the UL 
for nicotinamide from food sources.  
Assuming that exposure data are derived mostly from foods of animal origin, the population exposure 
provides a sufficient margin of safety (8 to 13) compared with the UL for nicotinamide. 
3.2.5.  Conclusions on consumer safety 
Since niacin supplementation to feedingstuffs of animals is in widespread routine use, the FEEDAP 
Panel assumes that above-mentioned population exposure figures already include the contribution of 
edible tissues and products of animals fed niacin-supplemented diets. 
The information on niacin metabolism and the limited data on retention in edible tissues and products 
indicate that even supplemental levels in feeds far higher than the requirements (1–35 mg/kg feed) are 
highly unlikely to cause any concern about consumers’ exposure exceeding the UL. 
The FEEDAP Panel considers that the use of niacin in animal nutrition is not of safety concern for 
consumers. 
3.3.  Safety for the user 
3.3.1.  Effects on the respiratory system 
Information on particle size distribution and dusting potential (see Sections 2.1.1 and 2.1.2) indicates 
that the nicotinic acid and nicotinamide under assessment have the potential to form dust that might 
contain large proportions of particles of respirable size. Inhalatory toxicity studies were not available. 
Consequently, the FEEDAP Panel concludes that inhalation exposure from handling nicotinic acid and 
nicotinamide could be hazardous. 
3.3.2.  Effects on the eyes and skin 
The acute dermal toxicity of nicotinic acid in rats and of nicotinamide in rabbits was low with an LD50 
greater than 2 000 mg/kg bw (in both cases) when tested in accordance with OECD Guideline 402.
33,34 
Nicotinic acid and nicotinamide were not irritant to the skin of rabbits when tested according to OECD 
Methodological Guideline 404.
35 They did however cause moderate (for nicotinic acid) or moderate to 
severe (for nicotinamide) eye irritation when tested in rabbits in acco rdance with OECD Guideline 
405.
36 
Nicotinic acid was ‘not sensitizing’ when tested in a guinea-pig maximisation test in accordance with 
OECD Guideline 406.
37 
The skin sensitisation potential of nicotinamide was tested in guinea-pigs in two studies.
38 A Buehler 
test gave a negative result, but used a group size (five animals of each sex in the treatment group and 
                                                       
33   Technical dossier/Section III/References III.7  
34   http://esis.jrc.ec.europa.eu/doc/existing-chemicals/IUCLID/data_sheets/98920.pdf 
35   Technical dossier/Section III/ References III.15 and III.14. 
36   Technical dossier/Section III/ References III.13 and III.12. 
37   Technical dossier/Section III/ References III.18. 
38   Technical dossier/Section III/ References III.16 and III.17. Nicotinic acid and nicotinamide for all animal species 
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two males and three females as controls) that was too small to be compliant with OECD Guideline 
406. A maximisation test that complied with OECD Guideline 406 showed a positive erythema score 
in 4 animals at 24 h post challenge and in 3 animals at 48 h, out of a group of 20 animals, but the 
OECD (Organisation for Economic Cooperation and Development) SIDS Initial Assessment Report 
(OECD, 2002)  interpreted this as a negative result. In addition, a survey of 50 000 patients at a 
German dermatological hospital found no cases of skin sensitisation to nicotinamide (OECD, 2002, 
Ref. 116). The FEEDAP concluded that exposure of workers to nicotinic acid and/or nicotinamide is 
unlikely to cause skin sensitisation. 
3.3.3.  Conclusions on user safety 
The FEEDAP Panel considers nicotinic acid and nicotinamide are not irritant to skin, but can cause 
irritancy to eyes and mucous membranes. They are unlikely to cause skin sensitisation. Workers might 
be  exposed  to  a respirable  dust  when  handling  nicotinic acid  and  nicotinamide,  which  should  be 
regarded as being potentially harmful to their health. 
3.4.  Safety for the environment 
Niacin occurs widely in nature. Free nicotinic acid (and nicotinamide) is present in nature in only 
small  amounts.  Nicotinic  acid  is  mainly  bound  to  macromolecules  such  as  polysaccharides  and 
peptides or glycopeptides in plants (see, for example, Mason et al., 1971, 1973), whereas nicotinamide 
is  usually  a  component  of  NAD(P)  in  all  animals.  Its  use  in  animal  nutrition  is  not  expected  to 
substantially increase the concentration in the environment. Therefore, the use of niacin in animal 
nutrition is not expected to pose a risk to the environment. 
4.  Efficacy 
According  to  Regulation  (EC)  No  429/2008,  efficacy  studies  are  not  required  for  vitamins,  pro-
vitamins and chemically well-defined substances having similar effects which are already authorised 
as feed additives. 
Due to the long history of use and its established nutritional role in domestic animals, nicotinic acid 
Owing to the long history of use and its established nutritional role in domestic animals, nicotinic acid 
and nicotinamide are regarded as effective sources of niacin, both having the same potency (Baker et 
al.,  1976).  Niacin  has  been  globally  used  in  animal  nutrition  for  decades.  Data  on  requirements, 
allowances and recommendations for feed supplementation are easily accessible as standard literature 
for animal nutrition experts. All data available in the public literature demonstrate that nicotinic acid 
and nicotinamide when fed to animals are efficacious sources of niacin (see, for example, Da Silva et 
al., 1952; Baker et al., 1976; Yen et al., 1978; Copelin et al., 1980; Waldroup et al., 1985; Harms et al., 
1988; Oduho and Baker, 1993; Real et al., 2002; Ivers and Veum, 2012).  
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
39  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Niacin is safe for the target animals with a margin of safety that is at least ten times the requirements 
and use levels. 
                                                       
39   Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Nicotinic acid and nicotinamide for all animal species 
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The information on niacin metabolism and the limited data on retention in edible tissues and products 
indicate that even supplemental levels in feeds far higher than the requirements are highly unlikely to 
lead to the UL being exceeded. The FEEDAP Panel considers that the use of niacin in animal nutrition 
is not of safety concern for consumers.  
Nicotinic acid and nicotinamide are not irritant to skin, but can cause irritancy to eyes and mucous 
membranes. They are unlikely to cause skin sensitisation. Workers might be exposed to a respirable 
dust when handling nicotinic acid and nicotinamide, which should be regarded as being potentially 
harmful to their health. 
The use of nicotinic acid and nicotinamide in animal nutrition does not pose a risk to the environment. 
Nicotinic acid and nicotinamide are regarded as effective sources of niacin in animal nutrition.  
RECOMMENDATION 
The FEEDAP Panel proposes to use the specifications for nicotinic acid and nicotinamide according to 
PhEur  (MG  0459  and  0047)  considering  purity,  substance related  impurities and  other impurities 
(sulphated ash). 
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1.  Nicotinic acid (niacin) and nicotinic acid amide (nicotinamide-niacinamide) for all animal species. 
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2.  Nicotinic acid (niacin) and nicotinic acid amide (nicotinamide-niacinamide) for all animal species. 
Supplementary information. February 2012. Submitted by Vertellus Specialties Belgium BV.  
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APPENDIX  
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed  Additives  on  the  Method(s)  of  Analysis  for  Niacin  (Nicotinic  acid)  and  Niacinamide 
(Nicotinamide)
40 
In the current application authorisation is sought under article 4(1)
1,2 (new use in water) and 10(2)
1-5  
for Niacin (Nicotinic acid) and Niacinamide (Nicotinamide) under the category/functional group 3(a) 
"nutritional additives"/"vitamins, pro-vitamins and chemically well defined substances having similar 
effect",  according  to  the  classification  system  of  Annex  I  of  Regulation  (EC)  No  1831/2003. 
Authorisation is sought for the use of the feed additive for all animal species and categories.  
According to the Applicants the products are white granular crystals or crystalline powder, containing 
a minimum of 99
3 % Niacin and a minimum of 98.5
3 % Niacinamide. The feed additive is intended to 
be processed in premixtures or added directly into feedingstuffs or in water. However, the Applicants 
did not specify any maximum or minimum concentration of Niacin and Niacinamide in feedingstuffs 
or water, as set in the previous regulations. 
For the determination of Niacin and Niacinamide in the feed additive, the Applicants propose various 
methods  including  the  internationally  recognised  European  Pharmacopoeia  methods  (Ph.  Eur.  6
th 
Edition, monograph 0459 for the determination of Niacin and monograph 0047 for the determination 
of Niacinamide). Even though no performance characteristics are provided, the EURL recommends 
for official control the European Pharmacopoeia methods to determine Niacin and Niacinamide in the 
feed additive. 
For the determination of Niacin and Niacinamide in premixtures, the Applicants propose two methods 
based on ion-pair Reversed Phase High Performance Liquid Chromatography coupled to UV detector 
(RP-HPLC-UV), namely (1) the method developed by VDLUFA (Association of German Agricultural 
Analytical and Research Institutes) and (2) a single-laboratory validated and further verified method 
submitted by one of the Applicants. The VDLUFA method was ring-trial validated with a Niacin and 
Niacinamide  content ranging from  3665 to 15540 mg/kg premixtures. The following performance 
characteristics  were  reported  for  Niacin  and  Niacinamide:  (i)  a  relative  standard  deviation  for 
repeatability  (RSDr)  ranging  from  3.49  to  7.58  %,  and  (ii)  a  relative  standard  deviation  for 
reproducibility (RSDR) ranging from 4.02 to 15.4 %.  
The above mentioned single-laboratory validated and further verified method is also suitable for the 
determination Niacin and Niacinamide in feedingstuffs. The performance characteristics of this method 
were recalculated by the EURL using the experimental data provided by the Applicant, to obtain: 
* For premixtures samples with contents ranging from 0.4 to 40 g/kg, for Niacin and Niacinamide: 
  RSDr ranging from 0.5 to 0.8 %; 
  RSDip (intermediate precision) ranging from 4.9 to 6.7 %; 
  RRec (recovery rate) ranging from 96.9 to 106.1 %, and 
* For feedingstuffs samples with contents ranging from 8 to 800 mg/kg: 
  RSDr ranging from 4.1 to 5.4 %; 
  RSDip ranging from 4.1 to 11.1 %; 
                                                       
40   The full report is available on the EURL website. http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
NiacineGroup.pdf 
1 FAD-2010-0112; 
2 FAD-2010-0263; 
3 FAD-2010-0198; 
4 FAD-2010-0265; 
5 FAD-2010-0397 Nicotinic acid and nicotinamide for all animal species 
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  RRec ranging from 95.7 to 107.0 %, and 
  LOD and LOQ of 2 and 8 mg/kg, respectively. 
For the determination of Niacin and Niacinamide in water the Applicant provided data, upon request 
of  the  EURL,  proving  that  the  method  for  premixtures  and  feedingstuffs  is  also  applicable  when 
analysing Niacin and Niacinamide in water, without any sample preparation except a simple dilution. 
Based  on  the  above  considerations  and  the  performance  characteristics  presented,  the  EURL 
recommends for official control the single-laboratory validated and further verified method submitted 
by  the  Applicant,  based  on  ion-pair  Reversed  Phase  High  Performance  Liquid  Chromatography 
coupled  to  UV  detector  (RP-HPLC-UV),  to  determine  Niacin  and  Niacinamide  in  premixtures, 
feedingstuffs  and  water,  within  the  concentration  range  covered  by  the  experimental  data. 
Additionally, the EURL recommends for official control the VDLUFA (Method Bd. III, 13.9.1) using 
RP-HPLC-UV, to determine Niacin and Niacinamide in premixtures. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 